Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Oct 21;24(1):2888.
doi: 10.1186/s12889-024-20330-1.

The epidemiology of asthma in Mainland China: a systematic review and meta-analysis

Jiarui Yu #  1   2 , Liang Xu #  3 , Azhu Han #  4   5 , Maomao Xie  6
Affiliations
Meta-Analysis

The epidemiology of asthma in Mainland China: a systematic review and meta-analysis

Jiarui Yu et al. BMC Public Health. .

Abstract

Background: Reliable estimates of asthma prevalence are essential for developing effective public health policies. However, discrepancies in published results have posed challenges for public health planning in China. To address this issue, we conducted this study to provide a comprehensive assessment of the epidemiology of asthma prevalence in China.

Methods: We conducted a thorough systematic review across multiple databases including PubMed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data, and Weipu database. The search was limited to studies published in either Chinese or English up to August 31, 2023, that reported on asthma prevalence in China. We extracted relevant study characteristics and performed meta-analyses. The study protocol was registered with PROSPERO (CRD42023397949).

Results: A literature search yielded 192 studies that met the inclusion criteria out of 17,152 articles. The overall prevalence of asthma in Mainland China was found to be 2.20% (95% confidence interval, CI: 1.96-2.47%; I2 = 99.8%), with the prevalence of ever asthma at 2.21%, current asthma at 2.16%, ever asthma-like symptoms at 14.36%, and current asthma-like symptoms at 3.01%. Using a random-effects model, the prediction interval ranged from 0.44 to 10.27%. Meta-analysis subgroups indicated that men or children and the elderly generally have a higher prevalence of asthma. In addition, the prevalence of asthma is higher in urban areas and in the East China. The prevalence of asthma has been on the rise over the past three decades, from 0.69% in 1984 to 5.30% in 2021. Projections suggest that the prevalence could reach 9.76% by 2050 for the Chinese population.

Conclusions: Asthma remains less prevalent in China than in western countries, however its prevalence has been gradually increasing over the past thirty years. The disease burden shows notable variations based on sex, age, and geographic regions, indicating significant demographic and regional disparities. To guide decision-making priorities and direct future research, conducting high-quality epidemiological studies on asthma is crucial.

Keywords: Asthma; China; Epidemiology; Meta-analysis; Prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of study selection
Fig. 2
Fig. 2
Prevalence of asthma among Chinese according to different subgroups
Fig. 3
Fig. 3
Prevalence of asthma in Mainland China by geographic region
Fig. 4
Fig. 4
Trend and forecast of asthma prevalence among the general Chinese population
See this image and copyright information in PMC

References

    1. Mortimer K, Lesosky M, García-Marcos L, Asher M, Pearce N, Ellwood E, Bissell K, El Sony A, Ellwood P, Marks G, et al. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. Eur Respir J. 2022;60(3):2102865. - PMC - PubMed
    1. Cloutier M, Dixon A, Krishnan J, Lemanske R, Pace W, Schatz M. Managing asthma in adolescents and adults: 2020 Asthma Guideline Update from the National Asthma Education and Prevention Program. JAMA. 2020;324(22):2301–17. - PubMed
    1. Safiri S, Carson-Chahhoud K, Karamzad N, Sullman MJM, Nejadghaderi SA, Taghizadieh A, Bell AW, Kolahi AA, Ansarin K, Mansournia MA et al. Prevalence, deaths, and disability-adjusted life-years due to Asthma and its attributable risk factors in 204 countries and territories, 1990–2019. Chest 2022, 161(2):318–29. - PubMed
    1. Asthma GIf. Global Strategy for Asthma Management and Prevention. Available from: www.ginaasthma.org; 2023.
    1. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88. - PMC - PubMed